NCT06665945View on ClinicalTrials.gov

The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer

RecruitingOBSERVATIONAL

Enrollment

245

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions

Ovarian Cancer

Interventions

DIAGNOSTIC_TEST

Platelet RNA expression

The SENTRY (Stability Enhanced Transcriptional Analytics) Study is to test whether combining a unique analytical approach with changes in platelet RNA expression accurately diagnoses ovarian cancer.

Trial Locations (1)

84112

RECRUITING

Huntsman Cancer Institute, Salt Lake City

All Listed Sponsors

lead

University of Utah

OTHER